Discarding logic2008 ancel keys memorial lecture

Circulation

Volumn 119, Issue 11, 2009, Pages 1533-1537

  Lauer, Michael S ^a,b,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b AMERICAN HEART ASSOCIATION   (United States)

^c NONE   (United States)

Author keywords

History; Prevention; Trials

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; BETA CAROTENE; VITAMIN;

ARTICLE; CANCER SCREENING; CARDIOVASCULAR DISEASE; HEART INFARCTION; HORMONE SUBSTITUTION; HYPERTENSION; LOGIC; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SCREENING; SMOKING; CARDIOLOGY; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL RESEARCH; PHILOSOPHY;

BIOMEDICAL RESEARCH; CARDIOLOGY; EVIDENCE-BASED MEDICINE; HUMANS; LOGIC; PHILOSOPHY, MEDICAL;

EID: 64949102321     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.842765     Document Type: Article

References (44)

1. Hendel RJ. Towards a definition of Torah. Proc Assoc Orthodox Jewish Scientists. 1976;3:171-189.
2. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J III. Factors of risk in the development of coronary heart disease: six year follow-up experience: the Framingham study. Ann Intern Med. 1961;55:33-50.
3. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med. 2005;142:233-239.
4. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP): SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264.
5. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, Lacy CR, Perry HM Jr, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. JAMA. 1997;278:212-216.
6. Findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1988;318:262-264.
7. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
8. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet.1993;341:973- 978.
9. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota Colon Cancer Control Study. N EnglJ Med. 1993;328:1365-1371.
10. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ,Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603-1607.
11. Ashton HA, Buxton MJ, Day NE, Kim LG, Marteau TM, Scott RA,Thompson SG, Walker NM. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360:1531-1539.
12. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123-2133.
13. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR,Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
14. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
15. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, the CAST Investigators. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.
16. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for met- astatic breast cancer: Philadelphia Bone Marrow Transplant Group. N Engl J Med. 2000;342:1069-1076.
17. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J. Hydrocortisone therapy for patients with septic shock. NEngl J Med. 2008;358:111-124.
18. Hartmann K, Viswanathan M, Palmieri R, Gartlehner G, Thorp J Jr, Lohr KN. Outcomes of routine episiotomy: a systematic review. JAMA. 2005;293:2141-2148.
19. McCullough D. The course of human events: 2003 Jefferson Lecturer in the Humanities. Available at: http://www.neh.gov/whoweare/mccullough/ lecture.html. Accessed December 2, 2008.
20. The Mark Twain House and Museum. Available at: http://www. marktwainhouse.org/theman/bio.shtml. Accessed December 2, 2008.
21. Lauer MS. Screening for coronary heart disease: has the time for universal imaging arrived? Cleve Clin J Med. 2007;74:645-650, 653-644, 656.
22. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP,Shaw LJ, Taylor AJ, Weintraub WS, Harrington RA, Abrams J, Anderson JL, Bates ER, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation. 2007;115:402-426.
23. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207.
24. Hecht HS. The deadly double standard (the saga of screening for sub- clinical atherosclerosis). Am J Cardiol. 2008;101:1805-1807.
25. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK. From vulnerable plaque to vulnerable patient, part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H-15H.
26. Marshall E. Medicine: a bruising battle over lung scans. Science. 2008;320:600-603.
27. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet.2002;359:881-884.
28. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, KleinG,Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346:1047-1053.
29. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S,Bunin G, Levy I, Brossard J, Dougherty G, Tuchman M, Lemieux B. Screening of infants and mortality due to neuroblastoma. N Engl J Med.2002;346:1041-1046.
30. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343:1627-1633.
31. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 2002;346:529-531.
32. HeartCam Preventive Heart Center quoting USA Today, June 1999. Available at: ttp://www.phillyheartcam.com/news-main.html. Accessed December 2, 2008.
33. Zlotowitz M, ed. Schottenstein Edition of the Talmud: English Full Size, Berachos. Vol 2. 2nd ed. Brooklyn, NY: Artscroll, 1998:53a,55a.
34. Deyo RA, Patrick DL. Hope or Hype : The Obsession With Medical Advances and the High Cost of False Promises. New York, NY: American Management Association; 2005.
35. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327:1459-1461.
36. Taubes G. Good Calories, Bad Calories: Challenging the Conventional Wisdom on Diet, Weight Control, and Disease. 1st ed. New York, NY: Knopf; 2007.
37. Orszag PR. Research on the Comparative Effectiveness of Medical Treatments: Options for an Expanded Federal Role. Washington, DC: Congressional Budget Office; 2007.
38. Orszag PR. Health Care and the Budget: Issues and Challenges for Reform (CBO Testimony Before the Committee on the Budget, United States Senate). Washington, DC: Congressional Budget Office; 2007.
39. Emanuel EJ. What cannot be said on television about health care. JAMA.2007;297:2131-2133.
40. Midwest Business Group on Health. Reducing the costs of poor-quality health care through responsible purchasing leadership. Available at: http:// www.mbgh.org/templates/UserFiles/Files/COPQ/copq%202nd%20 printing.pdf. Accessed October 29, 2008.
41. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med. 2008;148:956-961.
42. McClellan MB. Evidence-Based Medicine and the Changing Nature of Health Care: 2007 IOM Annual Meeting Summary. Washington, DC: National Academies Press; 2008.
43. Olsen L, Aisner D, McGinnis JM. Institute of Medicine (U.S.): Roundtable on Evidence-Based Medicine. The Learning Healthcare System: Workshop Summary. Washington, DC: National Academies Press; 2007.
44. Banke MT. A lesson about "history's lessons." OAHMag Hist. Available at: http://www.oah.org/pubs/magazine/sport/banker.html. Accessed March 2, 2009.